XML 14 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents, including restricted cash of $200 $ 4,265 $ 6,838
Investment in Eton Pharmaceuticals 28,000 21,420
Accounts receivable, net 2,194 1,914
Inventories 2,388 1,834
Prepaid expenses and other current assets 1,658 837
Total current assets 38,505 32,843
Property, plant and equipment, net 6,242 6,375
Operating lease right-of-use assets 6,195
Intangible assets, net 3,112 3,059
Goodwill 2,227 2,227
TOTAL ASSETS 66,510 49,451
Current liabilities    
Accounts payable and accrued expenses 6,143 6,250
Accrued payroll and related liabilities 1,092 2,283
Deferred revenue and customer deposits 359 119
Current portion of note payable, net of unamortized debt discount 2,552 2,529
Current portion of operating lease obligations 511
Current portion of finance lease obligations, net of unamortized discount 553 720
Total current liabilities 11,210 11,901
Operating lease obligations, net of current portion 6,083
Finance lease obligations, net of current portion and unamortized discount 32
Accrued expenses, net of current portion 800 800
Note payable, net of current portion and unamortized debt discount 11,351 11,999
TOTAL LIABILITIES 29,476 24,700
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY    
Common stock, $0.001 par value, 50,000,000 shares authorized, 24,718,649 and 24,339,610 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively 25 24
Additional paid-in capital 99,887 98,938
Accumulated deficit (62,853) (74,211)
TOTAL HARROW HEALTH, INC. STOCKHOLDERS' EQUITY 37,059 24,751
Noncontrolling interests (25)
TOTAL STOCKHOLDERS' EQUITY 37,034 24,751
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 66,510 49,451
Eton Pharmaceuticals [Member]    
Current assets    
Investment 28,000 21,420
Surface Pharmaceuticals [Member]    
Current assets    
Investment 4,704 4,947
Melt Pharmaceuticals [Member]    
Current assets    
Investment $ 5,525